BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21490440)

  • 1. Nevus versus melanoma: to FISH, or not to FISH.
    Song J; Mooi WJ; Petronic-Rosic V; Shea CR; Stricker T; Krausz T
    Adv Anat Pathol; 2011 May; 18(3):229-34. PubMed ID: 21490440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
    Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
    Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
    Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
    J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridisation (FISH) in histologically challenging conjunctival melanocytic lesions.
    Mudhar HS; Smith K; Talley P; Whitworth A; Atkey N; Rennie IG
    Br J Ophthalmol; 2013 Jan; 97(1):40-6. PubMed ID: 23137666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
    Gerami P; Mafee M; Lurtsbarapa T; Guitart J; Haghighat Z; Newman M
    Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
    Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
    J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies.
    Díaz A; Valera A; Carrera C; Hakim S; Aguilera P; García A; Palou J; Puig S; Malvehy J; Alos L
    Am J Surg Pathol; 2011 Nov; 35(11):1733-42. PubMed ID: 21997694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.
    Abásolo A; Vargas MT; Ríos-Martín JJ; Trigo I; Arjona A; González-Cámpora R
    Clin Exp Dermatol; 2012 Dec; 37(8):838-43. PubMed ID: 22731835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence in situ hybridization as a diagnostic modality in melanocytic neoplasma.
    Gerami P; Geraminegad P
    G Ital Dermatol Venereol; 2010 Feb; 145(1):29-35. PubMed ID: 20197743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridisation as an ancillary tool in the diagnosis of acral melanoma: a review of 44 cases.
    Su J; Yu W; Liu J; Zheng J; Huang S; Wang Y; Qi S; Ma X; Chen J; Zhang Y
    Pathology; 2017 Dec; 49(7):740-749. PubMed ID: 29037804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
    Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
    Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of molecular morphology techniques on the expert diagnosis in melanocytic skin neoplasms.
    Ferrara G; Misciali C; Brenn T; Cerroni L; Kazakov DW; Perasole A; Russo R; Ricci R; Crisman G; Fanti PA; Passarini B; Patrizi A
    Int J Surg Pathol; 2013 Oct; 21(5):483-92. PubMed ID: 23775023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ancillary values of fluorescence in situ hybridization with different gene combination in diagnosis of malignant melanoma].
    Ren M; Bai QM; Kong YY; Zhou XY; Chang H; Cai X
    Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):827-833. PubMed ID: 32746551
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
    Gammon B; Beilfuss B; Guitart J; Gerami P
    Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence In Situ Hybridization for Melanoma Diagnosis: A Review and a Reappraisal.
    Ferrara G; De Vanna AC
    Am J Dermatopathol; 2016 Apr; 38(4):253-69. PubMed ID: 26999337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
    Bauer J; Bastian BC
    Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
    de la Fouchardière A; Vergier B
    Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
    [No Abstract]   [Full Text] [Related]  

  • 18. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up.
    Gaiser T; Kutzner H; Palmedo G; Siegelin MD; Wiesner T; Bruckner T; Hartschuh W; Enk AH; Becker MR
    Mod Pathol; 2010 Mar; 23(3):413-9. PubMed ID: 20081813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
    Senetta R; Paglierani M; Massi D
    Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide high-resolution array-CGH analysis of cutaneous melanoma and comparison of array-CGH to FISH in diagnostic evaluation.
    Wang L; Rao M; Fang Y; Hameed M; Viale A; Busam K; Jhanwar SC
    J Mol Diagn; 2013 Sep; 15(5):581-91. PubMed ID: 23800576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.